Skip to main content
Premium Trial:

Request an Annual Quote

Millennium Takes License to Ingenuity Pathway Analysis Platform

NEW YORK, Aug. 9 (GenomeWeb News) - Ingenuity Systems said today that Millennium Pharmaceuticals has taken a three-year license to the Ingenuity Pathway Analysis platform, which allows researchers to generate biological networks from gene or protein datasets.


Under the companies' arrangement, Ingenuity will also provide Millennium with customized support for research efforts involving the Pathway Analysis technology.


Additional terms of the arrangement were not disclosed.


The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.